Company Search:
Advanced Search
Sponsored Links
Guerbet SA Company Snapshot
Guerbet SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guerbet SA with three other companies in this sector in France: Virbac (2016 sales of 871.83 million Euro [US$1.03 billion] of which 58% was Companion Animals), Boiron SA (614.49 million Euro [US$724.64 million] of which 51% was Non-Proprietary Homeopathic Medicines), and Vetoquinol Sa (350.35 million Euro [US$413.15 million] of which 76% was Europe).

Sales Analysis. During the year ended December of 2016, sales at Guerbet SA were 775.77 million Euro (US$914.83 million). This is an increase of 58.7% versus 2015, when the company's sales were 488.74 million Euro. This was the third consecutive year of growth at Guerbet SA. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 393.8% in 2016, from 4.40 million Euro to 21.72 million Euro. Guerbet SA also saw significant increases in sales in X-Rays (up 78.2% to 375.47 million Euro) and Medical Devices (Md) (up 257.2% to 76.80 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Guerbet SA
  Stock Performance Chart for Guerbet SA
  Stock Data: Recent Stock Performance:
  Current Price (11/10/2017): 74.10
(Figures in Euro)
1 Week -1.6%   13 Weeks -10.0%  
4 Weeks 1.5%   52 Weeks 34.7%  
Guerbet SA Key Data:
  Ticker: GBT Country: France
  Exchanges: FRA LON PAR OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 775,773,000
(Year Ending Jan 2017).
Employees: 2,679
  Currency: Euro Market Cap: 926,949,504
  Fiscal Yr Ends: December Shares Outstanding: 12,509,440
  Share Type: Actions Ordinaires Closely Held Shares: 7,273,466
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.